BIRD The Best Year Since The Pandemic Came With A Negative Cash Flow Quarter

The Best Year Since The Pandemic Came With A Capex Bill

FY2022 net revenue rose 61.65% YoY to Rp3,590.10 billion from Rp2,220.84 billion, and net income attributable to owners swung to Rp358.35 billion from a barely-positive Rp7.71 billion in FY2021 - a genuinely clean profitable year, not the near-breakeven print FY2021 technically was. Full-year operating income swung from a Rp16.15 billion loss to Rp419.91 billion, an 11.70% operating margin - the first full-year operating profit this site has recorded for Blue Bird since the pandemic began. Basic EPS rose to Rp143 from Rp3.

The quarter-by-quarter pattern this site tracked through Q1's Omicron-driven Taxi collapse, Q2's coverage-best snapback, and Q3's fresh records paired with a falling stock adds up, on a full-year basis, to the recovery actually landing. But standalone Q4 2022 (derived by subtracting the nine-month cumulative already reported through Q3 from this filing's full-year total) is where the year's cleanest number breaks: free cash flow swung to -Rp146.33 billion, the sharpest single-quarter reversal this site has recorded since Q4 2021's positive Rp142.60 billion, and the first negative FCF quarter since Q1 2022. The cause is disclosed plainly in this filing: full-year capital expenditure more than tripled to Rp939.57 billion from Rp252.52 billion in FY2021, as fleet renewal accelerated hard in the year's final quarter, partly funded by Rp177.27 billion in new long-term bank borrowing - the first fresh bank-loan proceeds this site has recorded for Blue Bird since the deleveraging campaign began.

The segment story flipped too. Non-Taxi's standalone Q4 operating margin reached roughly 25%, a new coverage-best comfortably ahead of Q2 2022's 17.37%, while Taxi's fell back to roughly 8.4% from Q3's 13.02% - breaking the pattern Q3's post highlighted of both segments performing near their own best levels simultaneously. See Segment Performance for the derived quarterly split.

The Prescription

Blue Bird should treat FY2022's capex surge as the headline capital-allocation story of the year, not a footnote buried under the profit swing - a company that just spent Rp939.57 billion renewing its fleet, more than triple the prior year, and needed fresh bank borrowing to help fund it, should disclose a forward fleet-renewal plan (target vehicle age, expected annual capex run-rate, financing mix) so a reader isn't left guessing whether Q4's negative free cash flow is a one-quarter spike or the start of a new multi-year investment cycle. What it should stop doing: letting a Supreme Court ruling that closed out, against the Company, a multi-year court fight tied to the 2017 Acer arbitration (see Beyond the Usual) pass with a single procedural paragraph and no discussion of what, if anything, it now owes or has to do differently - a case reaching permanent legal force after five years deserves more than the same boilerplate treatment given to still-open matters.

Key Financial Metrics

Q4 2022 vs. Q4 2021, standalone quarter (both derived by subtracting the nine-month cumulative from each filing's full-year total)

FX: IDR 15,731 = USD 1 (Bank Indonesia middle rate, December 31, 2022, as disclosed in this filing) - the Rupiah weakened a further 3.17% from Q3 2022's Rp15,247.

Metric	Q4 2022 (IDR)	Q4 2022 (USD)	Q4 2021 (IDR)	YoY
Net Revenue	Rp1,081.28B	~$68.7M	Rp770.99B	✅ +40.25%
Adjusted EBITDA»	Rp240.25B	~$15.3M	Rp200.54B	✅ +19.81%
Operating Income»	Rp132.78B	~$8.4M	Rp92.50B	✅ +43.54%
Net Income» (attributable to owners)	Rp97.72B	~$6.2M	Rp73.91B	✅ +32.23%
Free Cash Flow» (Op. CF minus capex)	-Rp146.33B	~-$9.3M	Rp142.60B	⚠️ Swung to negative
Total Cash (period-end)	Rp890.98B	~$56.6M	Rp945.64B	⚠️ -5.78%
EPS (basic, quarter, derived)	~Rp39	~$0.0025	~Rp30	✅ +32.23%

Every income-statement line grew YoY; the free cash flow line is the one that didn't. Sequentially, Q4 revenue rose 12.55% from Q3 2022's Rp960.76 billion, and operating income was essentially flat sequentially (Rp133.36B to Rp132.78B, down 0.44%). But free cash flow's reversal is the number this quarter is actually about: Q3 was positive Rp79.51 billion; Q4 swung to -Rp146.33 billion, a roughly Rp225.84 billion sequential deterioration, entirely explained by capex. Full-year capex of Rp939.57 billion, against the roughly Rp207-201 billion per quarter this site tracked through Q2 and Q3, points to a heavy fourth-quarter concentration of the year's fleet-renewal spending.

FY2022 vs. FY2021, full year (as reported directly in this filing, not derived)

Metric	FY2022 (IDR)	FY2022 (USD)	FY2021 (IDR)	YoY
Net Revenue	Rp3,590.10B	~$228.2M	Rp2,220.84B	✅ +61.65%
Adjusted EBITDA»	Rp867.90B	~$55.2M	Rp431.73B	✅ +101.03%
Operating Income»	Rp419.91B	~$26.7M	-Rp16.15B	✅ Swung to profit
Net Income» (attributable to owners)	Rp358.35B	~$22.8M	Rp7.71B	✅ +4,545%
Free Cash Flow» (Op. CF minus capex)	-Rp30.44B	~-$1.9M	Rp51.98B	⚠️ Swung to negative
Total Cash (period-end)	Rp890.98B	~$56.6M	Rp945.64B	⚠️ -5.78%
EPS (basic, full year)	Rp143	~$0.0091	Rp3	✅ +4,667%

The full-year and standalone-quarter reads tell slightly different stories on cash flow: FY2022's free cash flow (-Rp30.44 billion) is a much smaller shortfall than Q4 alone (-Rp146.33 billion) because Q1, Q2, and Q3 together still generated a combined Rp115.89 billion of positive free cash flow before Q4's capex surge wiped it out and then some. FY2021's positive Rp51.98 billion FCF, by contrast, means Blue Bird's free cash flow moved from positive to negative on a full-year basis for the first time since FY2020's pandemic-driven Rp335.88 billion shortfall - a materially different kind of shortfall, this time caused by discretionary reinvestment rather than a collapse in revenue.

Balance sheet metric	Dec 2022 (IDR)	Dec 2022 (USD)	Dec 2021 (IDR)	YoY Change
Total Assets	Rp6,893.16B	~$438.2M	Rp6,598.14B	✅ +4.47%
Total Liabilities	Rp1,542.47B	~$98.1M	Rp1,450.56B	⚠️ +6.34%
Total Equity	Rp5,350.69B	~$340.1M	Rp5,147.58B	✅ +3.94%
Debt-to-Equity Ratio» (per filing)	0.29x	-	0.28x	⚠️ Up from 0.28x

Against Q3 2022's balance sheet, total liabilities rose 8.65% (Rp1,419.52B to Rp1,542.47B) and total bank loans (current and non-current combined) rose from roughly Rp635.78 billion to Rp678.47 billion - the first sequential increase in total bank debt this site has recorded since the deleveraging campaign began, driven by the Rp177.27 billion in new long-term borrowing disclosed above, even as the company kept paying down its existing PT Bank BTPN Tbk-led facilities. This filing's own debt-to-equity figure (0.29x) again reconciles cleanly with a total-liabilities-over-equity calculation (Rp1,542.47B over Rp5,350.69B works out to almost exactly 0.29x), extending the clean read this site has now tracked since Q2 2022.

Segment Performance

Blue Bird still reports the same two operating segments - Taxi and Non-Taxi - unchanged since Q1 2016's two-segment collapse.

Taxi

FY2022 net revenue was Rp2,787.36 billion, up 72.01% YoY from FY2021's Rp1,620.61 billion, with a full-year operating margin of 9.51% (Rp264.98 billion operating income), swinging from FY2021's -3.17% loss margin. Standalone Q4 2022 (derived by subtracting the nine-month cumulative Taxi figures already reported through Q3 from this filing's full-year segment total) shows revenue of roughly Rp831.22 billion and operating income of roughly Rp69.71 billion - an ~8.4% margin, down from Q3 2022's 13.02% and back below Q1's 2.11%-to-12.52%-to-13.02% recovery arc for the first time since Q1. Segment assets, which had shrunk for three consecutive quarters even as revenue grew, reversed that pattern this quarter: Rp6,497.29 billion at year-end, up 2.66% from Q3 2022's Rp6,328.81 billion - consistent with the fleet-renewal capex disclosed above landing partly in this segment.

Non-Taxi

FY2022 net revenue was Rp803.02 billion, up 32.78% YoY from FY2021's Rp604.83 billion, with a full-year operating margin of 19.05% (Rp152.99 billion operating income), up from FY2021's 5.62%. Standalone Q4 2022 shows revenue of roughly Rp250.16 billion and operating income of roughly Rp62.45 billion - a margin near 25%, a new coverage-best for the segment, comfortably ahead of Q2 2022's then-record 17.37% and Q3's 16.73%. Segment assets rose 9.85% sequentially to Rp1,792.86 billion from Q3 2022's Rp1,632.09 billion - a second consecutive quarter of sequential growth, up 41.68% YoY from FY2021's Rp1,265.37 billion, the segment's largest asset-base expansion this site has recorded.

Segment Comparison

Segment	Revenue (FY2022)	YoY Growth	Operating Margin
Taxi	Rp2,787.36B (77.63%)	✅ +72.01%	✅ 9.51% (FY2022); -3.17% (FY2021)
Non-Taxi	Rp803.02B (22.37%)	✅ +32.78%	✅ 19.05% (FY2022); 5.62% (FY2021)

On a standalone Q4 basis, Taxi's share of the two segments' combined revenue fell to roughly 76.87% from Q3 2022's 78.38% - a second straight quarter Taxi's revenue share didn't rise, extending the reversal Q3's post first flagged. But the margin gap, which had narrowed to roughly 1.29x in Q3 after nearly 7x in Q1, widened sharply again this quarter: Non-Taxi's standalone Q4 margin is now closer to 3x Taxi's. This is the clearest evidence yet that Q2-Q3's "both segments near record simultaneously" read was itself a temporary alignment, not a new steady state - the two segments' margins have now moved in opposite directions for two straight quarters (Q3: Taxi up, Non-Taxi flat; Q4: Taxi down sharply, Non-Taxi up sharply), each taking turns being the stronger story rather than both compounding together.

Key Operational Metrics

• Weighted average shares outstanding: 2,502,100,000, unchanged since the IPO.
• Board of Commissioners short-term compensation (Group basis, full year): Rp7.26 billion, up 13.90% from FY2021's Rp6.37 billion.
• Board of Directors short-term compensation (Group basis, full year): Rp15.78 billion, up 43.87% from FY2021's Rp10.97 billion. Combined Board compensation for the year (Rp23.05 billion) is consistent with the quarterly pattern this site tracked all year - concentrated heavily around Q2's AGM and falling back the two quarters on either side of it.
• Total bank loans (current and non-current combined): roughly Rp678.47 billion, up from Q3 2022's Rp635.78 billion - the first sequential increase since the deleveraging campaign began, driven by new borrowing (see Key Financial Metrics).
• TAN's disclosed ownership: still not restated in this filing; last confirmed at 91.57% as of Dec 2019.
• Geographic revenue split (Jadetabek vs. outside Jadetabek) is still not disclosed, matching every prior filing.
• Still not available: any Gojek/GoPay integration volume or revenue metric, matching every filing since Q1 2020's first disclosure; this filing does disclose that the GoPay fleet-booking-and-payment integration agreement runs for 3 years from integration, without stating a start date.

Beyond the Usual

A five-year Acer-linked court fight reached a final, adverse ruling against the Company

This filing discloses that the Supreme Court of the Republic of Indonesia rejected the Company's own cassation appeal (Decision No. 2792 K/Pdt/2021, notice received November 9, 2022, copy of the decision received November 15, 2022), meaning the underlying ruling now has permanent legal force (inkracht). This closes out a case distinct from the original 2017 PT Acer Indonesia arbitration this site first flagged in the FY2017 filing and reported resolved in Blue Bird's favor in FY2019: here, the Company itself had sued to cancel the underlying 2015 Acer tablet-PC cooperation agreement, lost at the district court and on appeal, and this quarter's Supreme Court rejection closes off its last available avenue. No monetary quantum has been disclosed in any filing across this entire multi-year dispute, so the financial exposure from the underlying agreement remaining in force can't be sized from what's public - but a reader who only saw the FY2019 post's "resolved in Blue Bird's favor" framing would reasonably have assumed the whole Acer relationship was behind the Company; this filing confirms it wasn't, and now that the case has reached a final and permanent outcome, this is the last update this thread should need.

The new shareholder-rights lawsuit progressed from mediation to the evidentiary stage, still with no size disclosed

Last quarter's post flagged a July 2022 civil lawsuit naming the Company, some of its own shareholders, and affiliated companies as defendants over allegedly obstructed shareholder rights, then in mediation. This filing shows the case has moved to the verification (evidentiary) stage at the South Jakarta District Court, with no decision issued as of the filing's authorization date. The move from mediation to evidentiary proceedings means the case wasn't resolved or withdrawn at mediation - it's continuing to be actively litigated - though the filing still discloses nothing about the plaintiff's actual stake size or the specific affiliated companies involved, so the exposure remains unsized going into next year.

The related-party rent footnote's three-quarter run of a stale full-year comparative resolves cleanly in this annual filing: FY2022 related-party rent was Rp45.96 billion against total rental expense of roughly Rp69.64 billion, a 66.00% related-party share, down from FY2021's comparative 71.93% - confirming, on a genuine like-for-like annual basis, the gradual decline this site tracked quarter to quarter through Q1's 73.10%, Q2's 71.16%, and Q3's 62.83%. Standalone Q4 2022's related-party rent, derived the same way as everything else this quarter, comes to roughly Rp11.33 billion of an estimated Rp19.27 billion total rent - a 58.81% share, the lowest single-quarter figure this site has recorded, extending the decline into a fourth consecutive quarter.

On December 12, 2022, the Company formally canceled its remaining unrealized purchase of 6,925 square meters of land under the pre-IPO 2012 land purchase commitment with related parties (PBM, GBB, PCD, and certain shareholders) - the first disclosed cancellation of any part of that commitment. Of the original 133,133 square meters, 100,931 square meters had been purchased as of both December 2022 and every quarter tracked since June 2022, leaving 32,202 square meters unexecuted; this cancellation formally closes out roughly 21.5% of that remaining balance rather than leaving it open-ended indefinitely, the first real movement on the unexecuted portion since this site began tracking the commitment.

Target Valuation Range

Enterprise value ~Rp4,180B (~$265.7M), implying ~9.85x P/E (FY2022 actual) and ~0.67x P/B - roughly fairly valued to modestly undervalued. FY2022 delivered Blue Bird's first genuinely clean profitable year since the pandemic, but the stock's partial Q4 recovery still leaves it well below its mid-2022 peak, and the multiples now reflect a full year of real earnings rather than an annualized single quarter.

Blue Bird's stock closed FY2022 at Rp1,410 on December 30, 2022 (the last trading day of the year), up 4.06% from Q3 2022's Rp1,355 but still down 16.07% from Q2 2022's Rp1,680 two-year high. The partial recovery came without a matching change in the disclosed risk this site flagged last quarter - the government fuel-price increase - which this filing doesn't revisit or size.

Against the December 30, 2022 closing price of Rp1,410 (2,502,100,000 shares outstanding, unchanged):

Market cap → enterprise value	FY2022
Share price (period-end)	Rp1,410
Shares outstanding	2,502,100,000
Market capitalization	~Rp3,528.04B (~$224.3M)
Total liabilities	~Rp1,542.47B
Less: cash and equivalents	~Rp890.98B
Enterprise value	~Rp4,179.53B (~$265.7M)

Market cap is up 4.06% from ~Rp3,390.35B at Q3 2022's close.

Peer-multiple sanity check	Q3 2022 (annualized)	FY2022 (actual)
P/E	~7.41x	~9.85x (FY2022 net income Rp358.35B)
P/B	~0.66x	~0.67x (book value/share ~Rp2,098)
ROE	~8.97%	~6.96%
ROA	~6.94%	~5.40%

The gap between Q3's annualized multiples and FY2022's actual multiples is itself the finding. An annualized single quarter assumes that quarter repeats four times over; FY2022's real result shows the year didn't run at Q3's pace the whole way through - Q1's Omicron-driven collapse and Q4's capex-driven cash-flow reversal both pulled the full-year picture back toward the middle. On the actual, non-annualized numbers, Blue Bird enters 2023 priced at under 10x a genuinely clean year of earnings, with return-on-capital metrics that improved dramatically off FY2021's near-zero base but haven't yet reached the levels the best individual 2022 quarters showed in isolation - a reasonable, unglamorous starting point rather than either a bargain or a stretch.

---